Evidence map›Paper›PMID 42146528›Full record

ArticlebioRxiv : the preprint server for biology2026

A Phosphorylation Switch Modulates Configurational Codes in the Oncofetal IGF2BP RNA Binding Paralogs.

Vikas Kaushik, Vaishnavi Sanjayan, Jenna Mattice, Monika Tokmina-Lukaszewska, Ricarda Törner, Rahul Chadda, Rajnandani Kashyap, Abhinav Vayyeti, Pralambika Roy, Ryan A Mehl and 7 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Vikas KaushikDepartment of Biochemistry and Molecular Biology, St. Louis University School of Medicine, St. Louis, MO 63104.ORCID 0000-0001-6629-7693
Vaishnavi SanjayanDepartment of Biochemistry and Molecular Biology, St. Louis University School of Medicine, St. Louis, MO 63104.ORCID 0009-0003-1139-4287
Jenna MatticeDepartment of Chemistry and Biochemistry, Montana State University, Bozeman, MT 59717.ORCID 0000-0002-4493-1259
Monika Tokmina-LukaszewskaDepartment of Chemistry and Biochemistry, Montana State University, Bozeman, MT 59717.ORCID 0000-0003-3298-8298
Ricarda TörnerDana-Farber Cancer Institute, Boston, MA 02215.ORCID 0000-0002-0775-2075
Rahul ChaddaDepartment of Biochemistry and Molecular Biology, St. Louis University School of Medicine, St. Louis, MO 63104.ORCID 0000-0001-6710-3985
Rajnandani KashyapDepartment of Biochemistry and Molecular Biology, St. Louis University School of Medicine, St. Louis, MO 63104.ORCID 0000-0002-9141-1168
Abhinav VayyetiDepartment of Biochemistry and Molecular Biology, St. Louis University School of Medicine, St. Louis, MO 63104.ORCID 0009-0008-7283-1491
Pralambika RoyDepartment of Chemistry, Science Institute, University of Iceland, 107 Reykjavik, Iceland.ORCID 0009-0006-2920-480X
Ryan A MehlDepartment of Biochemistry & Biophysics, Oregon State University, Corvallis, OR 97331.ORCID 0000-0003-2932-4941
Richard B CooleyDepartment of Biochemistry & Biophysics, Oregon State University, Corvallis, OR 97331.ORCID 0000-0003-3928-2757
Snorri Th SigurdssonDepartment of Chemistry, Science Institute, University of Iceland, 107 Reykjavik, Iceland.
Reza DastvanDepartment of Biochemistry and Molecular Biology, St. Louis University School of Medicine, St. Louis, MO 63104.ORCID 0000-0002-4779-275X
Haribabu ArthanariDana-Farber Cancer Institute, Boston, MA 02215.ORCID 0000-0002-7281-1289
Brian B BothnerDepartment of Chemistry and Biochemistry, Montana State University, Bozeman, MT 59717.ORCID 0000-0003-1295-9609
Sofia OrigantiDepartment of Biology, Saint Louis University, St. Louis, MO 63103.ORCID 0000-0002-6953-0160
Edwin AntonyDepartment of Biochemistry and Molecular Biology, St. Louis University School of Medicine, St. Louis, MO 63104.ORCID 0000-0002-1888-054X

Funding

The GCE4All Center: Unleashing the Potential of Genetic Code Expansion for Biomedical ResearchRM1GM144227 · NIGMS · OREGON STATE UNIVERSITY · PI RYAN A MEHL · 2022 to 2026
$6.2M
Coordination of DNA Metabolism by Replication Protein AR35GM149320 · NIGMS · SAINT LOUIS UNIVERSITY · PI Edwin Antony · 2023 to 2026
$2.3M
Novel molecular mechanism for extracellular release of proteins implicated in metastatic cancerR37CA265877 · NCI · SAINT LOUIS UNIVERSITY · PI Reza Dastvan · 2022 to 2026
$2.1M
Mechanism and Regulation of eIF6 in TranslationR01GM143179 · NIGMS · SAINT LOUIS UNIVERSITY · PI Sofia Origanti · 2022 to 2026
$1.8M
High Q Technologies FATHOM Pulse EPR SpectrometerS10OD036230 · OD · SAINT LOUIS UNIVERSITY · PI DASTVAN, REZA · 2024 to 2024
$1.6M
Empowering NMR Utilization in Mechanistic Biology: Extending Size Limits and Catalyzing AutomationR35GM158220 · NIGMS · DANA-FARBER CANCER INST · PI Haribabu Arthanari · 2025 to 2026
$1.1M
Pre-synaptic events in homologous recombination and maintenance of genomic stabilityR01CA305375 · NCI · SAINT LOUIS UNIVERSITY · PI Edwin Antony · 2025 to 2026
$1.0M
Acquisition of an Optima Analytical UltracentrifugeS10OD030343 · OD · SAINT LOUIS UNIVERSITY · PI ANTONY, EDWIN · 2021 to 2021
$515k
NCI NIH HHS R01 CA305375NCI NIH HHS R37 CA265877NIGMS NIH HHS R01 GM143179NIGMS NIH HHS R35 GM149320NIGMS NIH HHS R35 GM158220NIGMS NIH HHS RM1 GM144227NIH HHS S10 OD030343NIH HHS S10 OD036230
6 · The paper itself

Abstract

The insulin-like growth factor 2 mRNA-binding proteins (IGF2BP1-3) are oncofetal RNA regulators that control translation, stability, and localization of several transcripts, yet display paralog-specific functions despite high structural similarity. Each paralog contains six RNA-binding domains (two RRMs and four KH domains) linked by intrinsically disordered segments. mTORC2 phosphorylates IGF2BP1 and IGF2BP3 at a single conserved serine within the disordered linker between the RRM2 and KH1 domains, a modification required for proper regulation of mRNA translational fate. Pairing site-specific phosphoserine incorporation with structural and biophysical interrogations, we show that this phosphorylation acts as a configurational switch that reorganizes long-range arrangements of RNA-binding domains and linkers without altering the secondary structure, and with only modest effects on RNA-binding affinity. Critically, pSer-driven rearrangements occur both in the RNA-free state and upon RNA engagement, and the resulting architectures differ markedly between IGF2BP1 and IGF2BP3 despite >70% sequence identity. These paralog-specific, phosphorylation-dependent configurational landscapes likely underlie differences in mRNA recognition modes and functional outcomes. Our work identifies a post-translational mechanism that tunes IGF2BP paralog dynamics across free and RNA-bound states to program target mRNA selection, processing, and translational fate.

Identifiers

PMID42146528
PMCPMC13174690

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.